Some users will not lose meaningful weight on drops alone
Peron JPS, Nakaya H (2020) Susceptibility of the elderly to SARS-COV-2 infection: ACE-2 overexpression, shedding, and antibody-dependent enhancement (ADE)
Weekly administration supports consistent GLP-1 receptor activation, making it suitable for patients who prefer less frequent dosing
Clinical Implications Beyond Diabetes and Obesity While retatrutide is being tested primarily for obesity and type 2 diabetes , its impact on LDL suggests future use in: Cardiovascular disease prevention (alongside statins or in statin-intolerant patients) Metabolic syndrome management Nonalcoholic fatty liver disease (NAFLD/NASH) , since LDL and triglyceride metabolism are central to liver health Complementary to Statins Unlike statins, which only reduce LDL synthesis, retatrutide may work through multiple lipid pathways , making it synergistic rather than redundant
Moleculen (Basel, Zwitserland) , 24 (18), 3251